![Ken Macnamara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Kenneth Macnamara is the founder of Trogenix Ltd., founded in 2023, holding the title of Chief Executive Officer & Director.
Dr. Macnamara currently holds the position of Chief Operating Officer at AskBio Inc. since 2019 and Chief Operating Officer at Synpromics Ltd.
Aktive Positionen von Ken Macnamara
| Unternehmen | Position | Beginn |
|---|---|---|
Synpromics Ltd.
 Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Geschäftsführer | - |
AskBio Inc.
 AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Geschäftsführer | 01.01.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
AskBio Inc.
AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Health Technology |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Process Industries |
Wählen Sie MarketScreener 
